TopCare Bismuth Stomach Relief

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: TopCare Bismuth Stomach Relief
Generic name: BISMUTH
Manufacturer: TopCo
Product type: HUMAN OTC DRUG
SPL set ID: 308f4b2a-22ff-42b9-e063-6394a90acc75
SPL ID: 308f4b2a-2300-42b9-e063-6394a90acc75
Version: 1
Effective date: 2025-03-17
Source export date: 2026-10-12
Source partition: 3
Source file: https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/f40eac55ff4c5d55c3d8bbc5766ea7e21e4196960cfb4703b96a406b491c0cd5/drug-label-0003-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 01:31:28

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M008	openfda.application_number
brand name		TopCare Bismuth Stomach Relief	openfda.brand_name
generic name		BISMUTH	openfda.generic_name
manufacturer name		TopCo	openfda.manufacturer_name
ndc	package	76162-406-24	openfda.package_ndc
ndc	product	76162-406	openfda.product_ndc
ndc11	package	76162040624	derived:openfda.package_ndc
rxcui		308761	openfda.rxcui
spl id		308f4b2a-2300-42b9-e063-6394a90acc75	id
spl set id		308f4b2a-22ff-42b9-e063-6394a90acc75	set_id
unii		62TEY51RR1	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Reye's syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use the product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye's syndrome, a rear but serious illness.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.